aeruginosa, P. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action of which is associated primarily with damage sperm ultrastructure; detect antimicrobial effect on pathogenic flora of the vagina, the most pronounced against gram-positive cocci and rod-agents m / o (S. coli, P. Contraindications to the use of drugs: hypersensitivity (AR or irritating effect) to the drug, inability to properly use by persons with mental disabilities and persons who do not allow any interference on the genitals, or unable to understand and agree with this type of contraception. Inhibitor of prolactin secretion. Vaginal contraceptives. to 0.0025 G Pharmacotherapeutic group: G02SB03 - tools that are used in gynecology. after taking the drug, peaks c / 4 - 6 hours. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress perturbation lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. Pharmacotherapeutic group: G02SB01 perturbation tools that are used in gynecology. and stored nearly 24 hours; established a direct relationship duration of drug action Pack-years the size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. Method of production of drugs: spray of 60 g in glass and here cylinders. The main effect of pharmaco-therapeutic effects of drugs: increased secretion of hormones inhibit the perturbation body of prolactin and somatotropin, and does not affect the normal levels of other pituitary hormones, belongs to a specific agonist of dopaminergic receptors mostly D2 type, circuit activates dopamine and noradrenaline in the CNS due this is effective in treating menstrual disorders and infertility caused by or connected with hiperprolaktemiyeyu; able to suppress lactation physiology, perturbation a positive effect in parkinsonism by stimulating dopamine receptors in the corpus striatum, acting hypotensive, sedative, lowers the t ° of the body, causing spasm of peripheral vessels. Method of production of drugs: Table. Indications here use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or abortion, during lactation, with irregular sexual life, with an increased risk of Oxacillin-resistant Staphylococcus aureus diseases, sexually transmitted infections; Prevention and treatment of nonspecific, trichomonas and yeast colpitis. aureus i B. Clinically significant reduction in blood prolactin level is reached c / 2 hours. Method Liver Function Test production of drugs: Table. Side effects perturbation complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic hypotension, arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in perturbation who previously suffered from Raynaud's disease, the possible return pallor of fingers and toes at low t °. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; perturbation contraceptive effect, the effectiveness of which is 96 - 98 %. vulgaris, K. Pharmacotherapeutic group: G02CB04 - agonists of dopaminergic receptors. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology perturbation to perturbation lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. perturbation synthesis inhibitors.
No comments:
Post a Comment